News
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.
The online market for weight-loss supplements is still a hot topic, and many patients have questions. Should physicians ever recommend supplements to patients?
Weight loss drugs helped me lose 85 pounds — and quieted my alcohol cravings Johnna Byrd swapped boozing and fast food for cute gym outfits.
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
For reduced risk of chronic disease and a better chance at a longer life, midlife weight loss may be helpful, a new study suggests.
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and investigational agents.
Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the drug after liver issues affected one patient.
Weight loss drug found in Mounjaro for use in sleep apnea patients approved by FDA Weight loss drugs known as GLP1s are all the rage right now. They were originally developed for diabetes and ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S. drugs regulator clamps down on mass production of copies of the in ...
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently approved medicine, Zepbound, but didn’t cleanly surpass it in late ...
Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s latest show of support for weight-loss drugs as he has pushed for making ...
This Fiber Supplement Can Help With Weight Loss—And Now, Brain Health. Should You Take It Every Day?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results